“●새로운●증산동오피여탑 ☞ yeotop2.com 증산동오피✢증산동휴게텔や증산동풀싸롱お증산동키스방➙증산동안마㏘증산동핸플”的搜索结果，显示 271-280 项，共有 8116 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to develop preclinical models that include cell lines and patient derived xenografts (PDX) that include molecular ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to develop preclinical models that include cell lines and patient derived xenografts (PDX) that include molecular ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

7. 妇产科- 临床试验- 妙佑医疗国际

   The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...